Quarter Financials
BiondVax Pharmaceuticals Ltd. (BVXV)
$1.7651
-0.09 (-5.10%)
Income Statement
Balance Sheet
Cash Flow
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Net Income | 4 | -13 | -9 | -11 | -9 | -12 | -8 | -14 |
|---|
| Dividend Paid | - | - | - | - | - | - | - | - |
|---|
| Retained Earnings | -383 | -387 | -374 | -365 | -354 | -345 | -333 | -325 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| Capital Expenditure | - | -0 | - | -0 | -0 | -0 | - | -0 |
|---|
| Net PPE | 44 | 44 | 45 | 44 | 44 | 45 | 45 | 46 |
|---|
|
Year
|
2022 Q3
|
2022 Q2
|
2022 Q1
|
2021 Q4
|
2021 Q3
|
2021 Q2
|
2021 Q1
|
2020 Q4
|
|---|
| New Purchases | - | - | - | - | - | - | - | - |
|---|
| Intangible and Goodwill | - | - | - | - | - | - | - | - |
|---|